How Beta-Blockers Affect Metabolism and Inflammation
Author Information
Author(s): Szymon Drygała, Michał Radzikowski, Mateusz Maciejczyk
Primary Institution: Medical University of Bialystok, Bialystok, Poland
Hypothesis
This review aims to report the impact of β-blockers on metabolic modulation based on available literature data.
Conclusion
Certain β-blockers, particularly nebivolol and carvedilol, may have favorable effects on metabolic parameters and glycemic control in patients with diabetes mellitus or cardiometabolic syndrome.
Supporting Evidence
- Nebivolol and carvedilol may improve insulin sensitivity and lipid metabolism.
- Vasodilatory β-blockers have potential therapeutic options for patients with metabolic disorders.
- The influence of β-blockers on glucose metabolism is complex and varies by patient population.
Takeaway
Beta-blockers are medicines that help with heart problems, and some of them can also help people with diabetes by improving how their bodies use sugar.
Methodology
This is a review article summarizing existing literature on the effects of β-blockers on metabolism and inflammation.
Limitations
Many findings were based on animal studies or small human cohorts, which limits the generalizability of the results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website